Cytokinetics Inc (CYTK)
53.93
+1.22
(+2.31%)
USD |
NASDAQ |
Jun 14, 16:00
53.96
+0.03
(+0.06%)
After-Hours: 20:00
Cytokinetics 1 Year Total Returns (Daily): 54.04% for June 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 14, 2024 | 54.04% |
| June 13, 2024 | 45.05% |
| June 12, 2024 | 50.28% |
| June 11, 2024 | 43.91% |
| June 10, 2024 | 46.26% |
| June 07, 2024 | 36.30% |
| June 06, 2024 | 38.56% |
| June 05, 2024 | 43.63% |
| June 04, 2024 | 25.32% |
| June 03, 2024 | 29.10% |
| May 31, 2024 | 28.71% |
| May 30, 2024 | 29.40% |
| May 29, 2024 | 28.10% |
| May 28, 2024 | 29.04% |
| May 24, 2024 | 26.64% |
| May 23, 2024 | 25.56% |
| May 22, 2024 | 45.35% |
| May 21, 2024 | 54.28% |
| May 20, 2024 | 55.46% |
| May 17, 2024 | 57.45% |
| May 16, 2024 | 60.95% |
| May 15, 2024 | 55.33% |
| May 14, 2024 | 57.70% |
| May 13, 2024 | 53.80% |
| May 10, 2024 | 58.30% |
| Date | Value |
|---|---|
| May 09, 2024 | 64.83% |
| May 08, 2024 | 69.93% |
| May 07, 2024 | 65.52% |
| May 06, 2024 | 64.93% |
| May 03, 2024 | 65.91% |
| May 02, 2024 | 72.45% |
| May 01, 2024 | 67.78% |
| April 30, 2024 | 63.96% |
| April 29, 2024 | 67.19% |
| April 26, 2024 | 75.93% |
| April 25, 2024 | 71.16% |
| April 24, 2024 | 74.37% |
| April 23, 2024 | 71.02% |
| April 22, 2024 | 72.90% |
| April 19, 2024 | 78.09% |
| April 18, 2024 | 82.07% |
| April 17, 2024 | 86.57% |
| April 16, 2024 | 98.39% |
| April 15, 2024 | 95.51% |
| April 12, 2024 | 110.2% |
| April 11, 2024 | 107.3% |
| April 10, 2024 | 112.5% |
| April 09, 2024 | 106.1% |
| April 08, 2024 | 103.7% |
| April 05, 2024 | 101.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-47.41%
Minimum
Oct 03 2023
178.1%
Maximum
Mar 18 2021
50.72%
Average
54.50%
Median
Apr 14 2020
1 Year Total Returns (Daily) Benchmarks
| Amgen Inc | 38.55% |
| Johnson & Johnson | -7.10% |
| Eli Lilly and Co | 97.65% |
| Madrigal Pharmaceuticals Inc | 8.13% |
| Viking Therapeutics Inc | 132.3% |